Drug Discovery Solutions

  1. Transient Expression Platform: discoCHO 10/4/2024

    Learn how this transient platform accelerates biologics production, seamlessly transitioning from discovery to stable CHO-K1, ensuring scalability, and reducing risks in manufacturing therapeutic biologics.

  2. Mammalian Cell Culture: Process R&D Services

    Lonza’s global R&D center for mammalian cell processes is based in Slough, UK alongside a custom manufacturing facility. Lonza undertakes highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries. Read more about Lonza’s complete range of R&D Services and an array of technologies and skills to best match their customers’ requirements for all stages of product development.

  3. Expediting Drug Discovery From Concept To Commercialization 8/13/2024

    Explore a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology and DMPK assays.

  4. Oncology Solutions: Accelerate Your Cancer Therapeutics Development 6/20/2022

    Aragen offers solutions from lead candidate selection to their development, preclinical trials, clinical trials, and GMP manufacturing under one roof.

  5. Bridging Molecules From Early Discovery To POC And Beyond 1/2/2024

    Learn how this partnership improves flexibility for customers, offers dedicated project teams, and enables a bespoke service that is tailored to each development program.

  6. Particle Control In Biopharmaceuticals

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

  7. PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production 3/17/2023

    PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.

  8. Early Phase Bioassays And Analytics 6/26/2024

    The development of phase-appropriate, tailored bioassays is crucial. By identifying promising candidates, bioassays streamline the development process, enabling informed decision-making.

  9. SUREtechnology Platform™ 8/4/2023

    Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.

  10. Cell Line Development 2/17/2022

    Our experience developing mammalian and microbial cell lines and our analytical capabilities enable us to identify and select clones that meet your product’s specific parameters and characteristics.